This bill would make MedPAC study PBM deals in Medicare drug plans and send Congress two reports. The reports would look at what patients pay and what pharmacies get paid. The bill itself does not change prices, payments, or benefits.
Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.
PBM Reporting Transparency Act is a Senate bill in committee. The latest recorded action: Read twice and referred to the Committee on Finance.
Latest action on S. 3729: Read twice and referred to the Committee on Finance.
Who this affects: This bill mainly affects Medicare patients with drug coverage, local and chain pharmacies, PBMs, and the Medicare drug plans that hire them. Congress and federal health officials would also use the reports to decide whether future rule changes are needed. The bill does not directly change what patients, pharmacies, or plans must pay right now.
Why this matters: This matters because Medicare drug pricing often works through deals the public cannot easily see. Congress wants a clearer picture of whether those deals raise costs for patients or squeeze pharmacy payments. These reports could help lawmakers decide if they should change PBM rules later. But this bill does not make those changes on its own.
You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.
